News
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023
aXess demonstrated exceptional patency rates and no infections to date
LimFlow Announces Agreement to Be Acquired by Inari Medical
Under the terms of the agreement, LimFlow will receive $250 million in cash at closing and be eligible to receive up to $165 million in additional payments based on certain commercial and reimbursement milestones, for a total potential transaction value of up to $415 million. The transaction is expected to close in the fourth quarter of 2023.
CorWave Announces the Grand Opening of Its Manufacturing Facility on the Banks of the Seine, next to Paris
With over 2,400m² of production, laboratory, and office space, bringing together its headquarters, R&D center and its first manufacturing facility of almost 1,000m². This world-class manufacturing facility will support the clinical trial phase and commercial scale-up.
M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials
In its first major MedTech investment, has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of the LimFlow System
FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options
New Therapeutic Option Has Potential to Reduce Rate of Major Limb Amputation in U.S.
Landmark New England Journal of Medicine Publication Reports Positive Results From PROMISE II Pivotal Trial
PROMISE II Trial Met Primary Endpoint
Therapy Demonstrates 76% Limb Salvage in Patients with Chronic Limb-Threatening Ischemia Who Otherwise Faced Amputation
